Paradigm Biocapital Advisors LP Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$3.5T
Holdings
34
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (34 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 5,269,433 | $455.7B | 12.96% | |
| 2 | MRUSMERUS N V | 4,673,770 | $440.0B | 12.51% | Call |
| 3 | ACLXARCELLX INC | 4,649,016 | $381.7B | 10.86% | |
| 4 | RVMDREVOLUTION MEDICINES INC | 6,223,291 | $290.6B | 8.27% | |
| 5 | TARSTARSUS PHARMACEUTICALS INC | 2,665,698 | $158.4B | 4.51% | |
| 6 | PCVXVAXCYTE INC | 3,784,755 | $136.3B | 3.88% | |
| 7 | ABVXABIVAX SA | 1,564,196 | $132.8B | 3.78% | |
| 8 | GMABGENMAB A/S | 3,816,851 | $117.1B | 3.33% | |
| 9 | AGIOAGIOS PHARMACEUTICALS INC | 2,873,555 | $115.3B | 3.28% | Call |
| 10 | CRNXCRINETICS PHARMACEUTICALS IN | 2,550,774 | $106.2B | 3.02% | |
| 11 | XBISPDR SERIES TRUST | 1,000,000 | $100.2B | 2.85% | Put |
| 12 | EWTXEDGEWISE THERAPEUTICS INC | 6,170,131 | $100.1B | 2.85% | |
| 13 | CDTXCIDARA THERAPEUTICS INC | 961,164 | $92.0B | 2.62% | |
| 14 | URGNUROGEN PHARMA LTD | 4,216,084 | $84.1B | 2.39% | |
| 15 | SRRKSCHOLAR ROCK HLDG CORP | 2,009,745 | $74.8B | 2.13% | |
| 16 | JANXJANUX THERAPEUTICS INC | 2,920,258 | $71.4B | 2.03% | |
| 17 | OLMAOLEMA PHARMACEUTICALS INC | 6,794,172 | $66.5B | 1.89% | |
| 18 | APGEAPOGEE THERAPEUTICS INC | 1,521,757 | $60.5B | 1.72% | |
| 19 | VRDNVIRIDIAN THERAPEUTICS INC | 2,609,353 | $56.3B | 1.60% | |
| 20 | ALKSALKERMES PLC | 1,719,334 | $51.6B | 1.47% | |
| 21 | LENZLENZ THERAPEUTICS INC | 1,073,461 | $50.0B | 1.42% | |
| 22 | PHVSPHARVARIS N V | 1,835,494 | $45.8B | 1.30% | |
| 23 | COGTCOGENT BIOSCIENCES INC | 3,156,398 | $45.3B | 1.29% | |
| 24 | OCULOCULAR THERAPEUTIX INC | 3,497,307 | $40.9B | 1.16% | |
| 25 | BBIOBRIDGEBIO PHARMA INC | 684,277 | $35.5B | 1.01% | |
| 26 | ERASERASCA INC | 13,560,017 | $29.6B | 0.84% | |
| 27 | EYPTEYEPOINT PHARMACEUTICALS INC | 2,005,365 | $28.6B | 0.81% | |
| 28 | TNGXTANGO THERAPEUTICS INC | 3,086,184 | $25.9B | 0.74% | |
| 29 | AMLXAMYLYX PHARMACEUTICALS INC | 1,900,000 | $25.8B | 0.73% | |
| 30 | SYRESPYRE THERAPEUTICS INC | 1,467,266 | $24.6B | 0.70% | |
| 31 | DYNDYNE THERAPEUTICS INC | 1,898,950 | $24.0B | 0.68% | |
| 32 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 1,866,141 | $21.6B | 0.61% | |
| 33 | IRONDISC MEDICINE INC | 247,716 | $16.4B | 0.47% | |
| 34 | GPCRSTRUCTURE THERAPEUTICS INC | 372,869 | $10.4B | 0.30% |